CD73 or NT5E (ecto-5?-nucleotidase) is a GPI-anchored enzyme that generates extracellular adenosine, a potent immunosuppressive metabolite in the tumor microenvironment. CD73?adenosinergic pathway contributes to tumor immune escape in animal mouse models of cancerand was also shown to suppress antitumor T cells in human ovarian cancer. Monoclonal antibody treatment targeting CD73 has been shown to delay ovarian tumor growth in mice and to rescue human T-cell functions when co-cultured with CD73-expressing human ovarian cancer cells. CD73 over expression was demonstrated in various cancer including breast cancer, colon cancer, glioma, leukemia, melanoma, ovarian cancer, pancreatic cancer, prostate cancer and thyroid cancer.
|Tissue Type/Cancer Type|
0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 100 Tests – Automation – i6000, 200 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual